Sigilon Therapeutics, Inc. (SGTX) Financials

NASDAQ Currency in USD Disclaimer

$22.47

north_east NA Past Year
Day's range
$22.09
Day's range
$23.08
$20M$20M$0$0-$20M-$20M-$40M-$40M-$60M-$60M-$80M-$80MEarning20182018201920192020202020212021202220220%0%-200%-200%-400%-400%-600%-600%-800%-800%-1000%-1000%Profit Margin
Profit Margin
Revenue
Earnings

SGTX Income statement / Annual

Last year (2022), Sigilon Therapeutics, Inc.'s total revenue was $12.94 M, an increase of 34.85% from the previous year. In 2022, Sigilon Therapeutics, Inc.'s net income was -$43.46 M. See Sigilon Therapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2022 FY-2021 FY-2020 FY-2019 FY-2018
Period Ended 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018
Operating Revenue $12.94 M $9.60 M $13.37 M $14.16 M $4.64 M
Cost of Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit $12.94 M $9.60 M $13.37 M $14.16 M $4.64 M
Gross Profit Ratio 1 1 1 1 1
Research and Development Expenses $37.63 M $65.07 M $53.49 M $48.11 M $21.04 M
General & Administrative Expenses $18.98 M $20.17 M $12.53 M $10.17 M $6.67 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $18.98 M $20.17 M $12.53 M $10.17 M $6.67 M
Other Expenses $1.45 M $55,000.00 -$89,000.00 -$6,000.00 -$81,000.00
Operating Expenses $56.61 M $85.24 M $66.02 M $58.28 M $27.71 M
Cost And Expenses $56.61 M $85.24 M $66.02 M $58.28 M $27.71 M
Interest Income $946,000.00 $258,000.00 $312,000.00 $1.06 M $698,000.00
Interest Expense $2.29 M $1.99 M $1.20 M $650,000.00 $289,000.00
Depreciation & Amortization $2.40 M $313,000.00 $223,000.00 $1.73 M $374,000.00
EBITDA -$41.27 M -$75.32 M -$52.42 M -$42.40 M -$22.08 M
EBITDA Ratio -3.19 -7.85 -3.92 -3 -4.76
Operating Income Ratio -3.37 -7.88 -3.94 -3.12 -4.98
Total Other Income/Expenses Net $105,000.00 -$1.68 M -$1.97 M $198,000.00 $310,000.00
Income Before Tax -$43.56 M -$77.31 M -$54.61 M -$43.93 M -$22.77 M
Income Before Tax Ratio -3.37 -8.05 -4.08 -3.1 -4.91
Income Tax Expense -$105,000.00 $925,000.00 $259,000.00 $644,000.00 $599,000.00
Net Income -$43.46 M -$78.24 M -$54.87 M -$44.57 M -$22.77 M
Net Income Ratio -3.36 -8.15 -4.1 -3.15 -4.91
EPS -1.34 -31.92 -22.67 -27.53 -18.85
EPS Diluted -1.34 -31.92 -22.67 -27.53 -18.85
Weighted Average Shares Out $32.41 M $2.45 M $2.42 M $1.62 M $1.21 M
Weighted Average Shares Out Diluted $32.41 M $2.45 M $2.42 M $1.62 M $1.21 M
Link